NanoString Technologies traded at $0.09 this Tuesday April 9th, increasing $0.01 or 8.55 percent since the previous trading session. Looking back, over the last four weeks, NanoString Technologies gained 51.42 percent. Over the last 12 months, its price fell by 99.04 percent. Looking ahead, we forecast NanoString Technologies to be priced at 0.09 by the end of this quarter and at 0.08 in one year, according to Trading Economics global macro models projections and analysts expectations.
NanoString Technologies, Inc. develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. The Company's nCounter Analysis System is an automated, multi-application, digital detection and counting system, which directly profiles hundreds of molecules simultaneously using a barcoding technology. The Company markets systems and related consumables to researchers in academic, government and biopharmaceutical laboratories for use in understanding fundamental biology and the molecular basis of diseases, such as cancer, and to clinical laboratories and medical centers for diagnostic use.